Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Tetra Bio Pharma Inc TBPMQ

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to... see more

GREY:TBPMQ - Post Discussion

Tetra Bio Pharma Inc > Reduvo approval
View:
Post by Golddetector on Oct 28, 2021 7:08pm

Reduvo approval

Beside revenue generation, ppl will start looking at tetra more a pharma. A big jump in sp is expected once the announcement comes in the next couple of months. Fda already approved this beside other countries. Tetra also doing adverse same drug but different naming in the us. below details
 

Dronabinol is marketed as Marinol and Syndros,[20] a registered trademark of Solvay Pharmaceuticals. Dronabinol is also marketed, sold, and distributed by PAR Pharmaceutical Companies under the terms of a license and distribution agreement with SVC pharma LP, an affiliate of Rhodes Technologies for Marinol and Insys Pharmaceuticals for Syndros.[citation needed] Dronabinol is available as a prescription drug (under Marinol and Syndros [21]) in several countries including the United StatesGermanySouth Africa and Australia.[22] In Canada, Tetra Bio-Pharma filed a New Drug Submission (NDS) with Health Canada for its Dronabinol Soft Gel capsules to be marketed as REDUVO™.[23] Tetra has two other dronabinol drugs with new routes of administration which limit first-pass metabolism; an inhaled THC-based dronabinol drug and their mucoadhesive-delivery dronabinol drug Adversa®, which are both in the accelerated 505(b)(2) New Drug Application (NDA) pathway for the U.S. and Canadian markets.[24]


m
ore detail can be found in link below
https://en.wikipedia.org/wiki/Dronabinol

Comment by BPP1976 on Oct 28, 2021 9:24pm
We are on the right path when paid bashers come out in force! They are worried about their jobs. Good times are just about to start with revenue generating products.
Comment by Golddetector on Oct 28, 2021 10:01pm
Correct. These guys are here for a reason. I don't see these comments anymore. It is on my ignore list now. Typically worthless. Anyway. I looked at health Canada website Every month they have few applications approved but did not see any for October yet. As I said we have only 5 similar applications so figured cross but not expecting anything before next week. Good luck longs.
Comment by Kingofstockst on Oct 28, 2021 10:28pm
That's what I've always said, block the noise on this case it's these paid basher prices... glta
Comment by Golddetector on Nov 02, 2021 9:24am
November already here so it should be anytime now. Gl guys. Beside revenue generation, ppl will start looking at tetra more a pharma. A big jump in sp is expected once the announcement comes in the next couple of months. Fda already approved this beside other countries. Tetra also doing adverse same drug but different naming in the us. below details   Dronabinol is marketed as Marinol ...more  
Comment by DONOOW on Nov 02, 2021 9:38am
2 months to get an update, so Dr pumperland be creative this time ;)
Comment by Kingofstockst on Nov 02, 2021 9:49am
Looking forward to that NR glta
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities